1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) and methylthymidine

1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) has been researched along with methylthymidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Balzarini, J; Bohman, C; Camarasa, MJ; De Clercq, E; Naesens, L; Pérez-Pérez, MJ; San-Félix, A	1

Other Studies

1 other study(ies) available for 1-(2',5'-bis-o-(tert-butyldimethylsilylribofuranosyl)-3-n-methylthymine)-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dioxide) and methylthymidine

Article	Year
Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N- methyl-thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dio xide). Biochemical pharmacology, 1993, Jul-06, Volume: 46, Issue:1 Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Half-Life; HIV-1; Humans; Metabolic Clearance Rate; Mice; Models, Chemical; Spiro Compounds; Thymidine; Thymidine Kinase; Thymidine Phosphorylase; Tissue Distribution; Tritium; Uridine	1993

Article

Year

Metabolism and pharmacokinetics of the anti-HIV-1-specific inhibitor [1-[2',5'-bis-O-(tert-butyldimethylsilyl)-beta-D-ribofuranosyl]-3-N- methyl-thymine]-3'-spiro-5''-(4''-amino-1'',2''-oxathiole-2'',2''-dio xide).

Biochemical pharmacology, 1993, Jul-06, Volume: 46, Issue:1

Topics: Animals; Antiviral Agents; CD4-Positive T-Lymphocytes; Cell Line; Half-Life; HIV-1; Humans; Metabolic Clearance Rate; Mice; Models, Chemical; Spiro Compounds; Thymidine; Thymidine Kinase; Thymidine Phosphorylase; Tissue Distribution; Tritium; Uridine

1993